xen1101
Small moleculeexperimental
Clinical trial activity
15 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
12
Phase 3
9
Phase 4
0
Earliest trial started Oct 16, 2017 (NCT03340220)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(N2CCc3cc(F)ccc3C2)cc(C)c1NC(=O)CC(C)(C)C- Mol. weight
- 368.5 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095264 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07217860 | Phase 3 | Oct 31, 2025 | Xenon Pharmaceuticals Inc. |
| NCT07172516 | Phase 3 | Aug 8, 2025 | Xenon Pharmaceuticals Inc. |
| NCT07076407 | Phase 3 | Jul 8, 2025 | Xenon Pharmaceuticals Inc. |
| NCT06922110 | Phase 3 | Mar 18, 2025 | Xenon Pharmaceuticals Inc. |
| NCT06775379 | Phase 3 | Dec 20, 2024 | Xenon Pharmaceuticals Inc. |
| NCT05716100 | Phase 3 | May 9, 2023 | Worldwide Clinical Trials, Xenon Pharmaceuticals Inc. |
| NCT05718817 | Phase 3 | Apr 25, 2023 | Worldwide Clinical Trials, Xenon Pharmaceuticals Inc. |
| NCT05667142 | Phase 3 | Dec 31, 2022 | Worldwide Clinical Trials, Xenon Pharmaceuticals Inc. |
| NCT05614063 | Phase 3 | Nov 18, 2022 | Worldwide Clinical Trials, Xenon Pharmaceuticals Inc. |
| NCT05376150 | Phase 2 | May 19, 2022 | Xenon Pharmaceuticals Inc. |
| NCT04827901 | Phase 2 | Oct 19, 2021 | Baylor University, Icahn School of Medicine at Mount Sinai, National Institute of Mental Health (NIMH) |
| NCT04952467 | Phase 1 | Aug 7, 2021 | Xenon Pharmaceuticals Inc. |
| NCT03796962 | Phase 2 | Jan 30, 2019 | NCGS, Inc., Xenon Pharmaceuticals Inc. |
| NCT03468725 | Phase 1 | Feb 13, 2018 | Xenon Pharmaceuticals Inc. |
| NCT03340220 | Phase 1 | Oct 16, 2017 | Xenon Pharmaceuticals Inc. |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | For profit | 14 | 14 | 3 | 2017 |
| Worldwide Clinical Trials | For profit | 4 | 0 | 1 | 2022 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 1 | 1 | 2021 |
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2021 |
| NCGS, Inc. | For profit | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1